SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 124 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,759,000 | +553.9% | 14,761 | +499.1% | 0.08% | +435.7% |
| Q4 2018 | $269,000 | -68.0% | 2,464 | -61.3% | 0.01% | -53.3% |
| Q2 2018 | $841,000 | +108.2% | 6,364 | +16.7% | 0.03% | +100.0% |
| Q1 2018 | $404,000 | +91.5% | 5,455 | -22.9% | 0.02% | +150.0% |
| Q2 2014 | $211,000 | – | 7,076 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 87,180 | $2,581,000 | 3.60% |
| Perceptive Advisors | 1,771,029 | $52,422,000 | 2.99% |
| SPHERA FUNDS MANAGEMENT LTD. | 483,047 | $14,298,000 | 2.80% |
| HealthCor Management, L.P. | 1,550,000 | $45,880,000 | 2.10% |
| Camber Capital Management LP | 1,350,000 | $39,960,000 | 1.62% |
| Tourbillon Capital Partners, L.P. | 1,537,518 | $45,511,000 | 1.17% |
| Elk Creek Partners, LLC | 562,522 | $16,651,000 | 1.02% |
| EMERALD ADVISERS, LLC | 818,705 | $24,234,000 | 1.00% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 604,467 | $17,892,000 | 0.82% |
| Carlson Capital, L.P. | 1,845,702 | $54,633,000 | 0.70% |